Disease Modification Of Parkinson's Disease Through Oral Kinase Inhibitor Therapy

Disease Modification of Parkinson's Disease Through Oral Kinase Inhibitor Therapy

Inhibikase Therapeutics

Abl Kinase Inhibition: Disease Modifying Strategy For Parkinson’s Disease

Inhibikase Therapeutics

The challenges in disease-modifying therapy development in Parkinson’s disease

Alpha-synuclein inhibitors, kinase inhibitors & targeting mitochondria in Parkinson’s disease

Parkinson's disease: updates in the disease-modifying space

Disease Modification in Parkinson’s Disease

Parkinson's Foundation

What's New in Parkinson's Research - UF PD Educational Symposium 2024

Norman Fixel Institute for Neurological Diseases

Update on disease-modifying therapies in Parkinson’s disease

Promising approaches in Parkinson’s disease treatment

How can we cure Parkinson's?

Inhibikase Therapeutics: Developing Therapies to Reverse Parkinson’s Disease

Inhibikase Therapeutics

Analysis of the therapeutic potential of c-Abl inhibition in Parkinson's disease & MSA

Role of Botulinum Toxin in Parkinson's Disease and Overview of Novel Therapies

New drugs for treatment of Parkinson’s disease

What are the Treatment Options for Parkinson's Disease?

Norton Healthcare

New Research: Disease Modifying Treatment of Parkinson's Disease

ParkinsonsDiseaseCNI

TradeTalks: Therapies designed to modify Parkinson’s Disease in the brain and GI tract

Treating Parkinson’s disease with gene editing

2019 UNMC Parkinson's Disease Conference - How Can We Cure Parkinson's Disease? Part Two

Inhibikase: Innovating Kinase Inhibitor Therapeutics for Neurodegenerative Diseases

Inhibikase Therapeutics